• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Blood Transcriptome Analysis Links Substance Dependence to Persistent Neuroimmune Gene Alterations

by
November 14, 2026
in Health
Reading Time: 6 mins read
0
Blood Transcriptome Analysis Links Substance Dependence to Persistent Neuroimmune Gene Alterations

Blood Transcriptome Analysis Links Substance Dependence to Persistent Neuroimmune Gene Alterations

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Researchers investigating the molecular architecture of substance dependence have identified distinct gene expression signatures in the peripheral blood of affected patients, demonstrating that chronic exposure to alcohol and other psychoactive substances is accompanied by systemic immune and metabolic alterations. The investigation, led by Dr. Anna Yakovchik and colleagues from biomedical research institutions in Moscow, evaluated transcriptomic profiles alongside comprehensive clinical, behavioral, and psychometric assessments across a clinical cohort of 555 participants. By analyzing total RNA isolated from whole blood rather than postmortem brain tissue, the investigators sought to identify circulating transcriptomic alterations that reflect the biological disruptions associated with substance use disorders. Their findings demonstrate that chronic consumption of addictive substances is linked to marked changes in RNA abundance, particularly involving genes and pathways associated with innate immunity, cellular inflammatory responses, hypoxia signaling, and central energy metabolism, while alcohol use disorder displayed additional transcriptomic disruptions tied to neurodegenerative pathways.

Understanding the biological mechanisms that drive chronic addiction has historically presented severe experimental hurdles, largely because molecular assessments of the central nervous system in living patients are clinically inaccessible. While prior postmortem examinations of human brain tissue have established that persistent substance exposure alters transcriptional programs within reward structures like the nucleus accumbens and prefrontal cortex, such investigations cannot capture active, systemic disease processes across diverse living patient populations. To address this gap, the research team recruited 383 inpatient individuals undergoing treatment at a specialized substance abuse facility alongside 172 healthy controls without a history of substance use disorders. The clinical cohort was carefully stratified into three distinct diagnostic groups: 308 individuals diagnosed with alcohol use disorder, 42 individuals diagnosed with psychoactive substance use disorders involving non-alcohol substances, and 33 individuals presenting with concurrent polyaddiction to both alcohol and psychoactive substances, allowing direct comparison across different clinical forms of dependence.

To ensure high phenotypic resolution across the participant groups, the researchers conducted detailed clinical and behavioral evaluations using validated psychological instruments and medical history reviews. Cognitive and personality measures included Maddi’s Personal Views Survey to evaluate hardiness and distress tolerance, the Zverkov and Eidman volitional self-regulation questionnaire to quantify self-control, and the Spielberger State-Trait Anxiety Inventory alongside Beck’s Depression Inventory to characterize affective status. Furthermore, licensed addiction specialists administered the Buss-Perry Aggression Questionnaire, the Barratt Impulsiveness Scale, the Alcohol Use Disorders Identification Test, and the Addiction Severity Index to map drug craving, consumption trajectories, and rehabilitation potential. To eliminate critical confounding infectious pathologies that could obscure transcriptional signaling, individuals diagnosed with human immunodeficiency virus or viral hepatitis were excluded from participation prior to enrollment.

Clinical and demographic baseline metrics revealed profound divergences across the study cohorts. The group with alcohol use disorder had a median age of 44 years and was predominantly male at 81 percent, whereas the cohort with other psychoactive substance use disorders exhibited a median age of 27.5 years and comprised 71 percent men. Analyses of lifetime substance exposure indicated that the alcohol use disorder group was characterized by an older age at initial substance consumption, longer durations of steady drinking averaging 16 years, less frequent psychotic episodes, and higher overall rehabilitation potential scores. In contrast, patients with psychoactive substance dependencies exhibited higher rates of substance-induced psychosis and markedly lower rehabilitation potential ratings, highlighting distinct clinical phenotypes.

Multivariable linear regression modeling adjusting for participant age demonstrated statistically significant relationships between behavioral control dimensions and lifetime substance exposure duration. Impulsivity scores measured by the Barratt Impulsiveness Scale correlated positively and robustly with both the duration of steady psychoactive substance use, with a regression coefficient of 1.34 and a significance value below 0.001, and the duration of steady alcohol intake, with a regression coefficient of 1.27 and significance below 0.001. Conversely, volitional self-control demonstrated an inverse association with the duration of steady psychoactive substance exposure, yielding a regression coefficient of negative 0.11 at a significance value of 0.037. Although self-control displayed a weak positive correlation with steady alcohol duration, with a coefficient of 0.06 at p equals 0.018, these behavioral metrics confirmed that prolonged chronic exposure across distinct addictive substances closely tracks severe disruption in behavioral inhibition and affective autoregulation.

For molecular profiling, whole blood was collected using Tempus Blood RNA tubes, and total RNA was purified using specialized spin isolation columns. The integrity and concentration of the extracted RNA were strictly evaluated through fluorometric quantification, spectrophotometric absorbance ratio checking between 1.8 and 2.2, and high-sensitivity automated screen tape electrophoretic assays, requiring an RNA integrity number above five. Sequencing libraries were constructed from 1,000 nanograms of RNA per participant using stranded total RNA protocols with ribosomal RNA depletion, followed by paired-end sequencing of 100-base-pair reads on an Illumina NovaSeq 6000 platform to achieve a sequencing depth of approximately 100 million reads per sample. Transcript abundance was quantified against the GRCh38 human reference genome and Gencode annotations using Salmon, while differential expression analysis was executed using DESeq2 with age, sex, and sequencing batch included as analytical covariates.

The initial differential expression analysis comparing participants with combined alcohol and psychoactive substance dependence against healthy controls identified 2,777 differentially expressed genes across a filtered background of 17,082 detectable genes, comprising 1,676 downregulated and 1,101 upregulated transcripts. To rigorously address confounding clinical variables such as somatic deterioration and ongoing inpatient pharmacological therapies, the investigators performed extensive sensitivity analyses through sequential subgroup elimination. These iterations removed cohorts receiving active pharmacological medication, as well as specific user groups consuming opioids, psychostimulants, cannabinoids, or tranquilizers. Furthermore, unsupervised principal component analysis across all 51,105 quantified transcripts demonstrated that global variance was not driven merely by broad demographic categories such as sex, chronological age, or raw duration of substance use, confirming that identified expression changes reflected biological alterations rather than basic demographic stratification.

Through gene set intersection analysis across all sensitivity subtraction models, the research team isolated a core group of 98 persistent differentially expressed genes that remained altered regardless of subgroup removal, representing non-specific candidate transcriptomic markers of addiction. This shared signature was evenly divided between 49 upregulated and 49 downregulated genes. Among these persistent transcripts, the most pronounced increases were observed in CD177, which showed a log2 fold change of 1.52 with an adjusted p-value of 4.38 times 10 to the negative fifth power, and GPR15, exhibiting a log2 fold change of 1.21 and an adjusted p-value of 7.33 times 10 to the negative eleventh power. Both genes play pivotal roles in leukocyte biology and inflammatory signaling, as CD177 mediates neutrophil activation and proliferation, while GPR15 functions as a chemokine receptor responsive to environmental toxins and aryl hydrocarbon receptor activation. Concurrently, significant downregulation occurred in CACNB4, encoding a voltage-dependent calcium channel subunit, and TP53INP2, which regulates cellular stress, apoptosis, and autophagy.

When examining patients with alcohol use disorder specifically, the authors identified an expanded pool of 623 candidate transcriptomic markers whose differential expression persisted across other exclusions but disappeared when alcohol dependence cases were excluded. This disease-specific profile comprised 412 downregulated and 211 upregulated transcripts. Markedly upregulated transcripts within this alcohol-specific cohort included ELANE, which encodes neutrophil elastase and demonstrated a log2 fold change of 1.67, alongside the innate immune regulator OLFM4 with a log2 fold change of 1.40, the classical complement pathway component C1QB with a log2 fold change of 1.31, slow skeletal muscle troponin T encoded by TNNT1 with a log2 fold change of 1.19, and the microbicidal enzyme myeloperoxidase encoded by MPO with a log2 fold change of 1.02. Conversely, DAAM2, a gene critical for oligodendrocyte differentiation, myelin compaction, and actin cytoskeleton polymerization, was substantially downregulated with a log2 fold change of negative 1.42.

Functional over-representation analysis mapping the differentially expressed genes against the Kyoto Encyclopedia of Genes and Genomes database revealed divergent pathway perturbations between broad substance dependence and isolated alcohol use disorder. Across all addiction groups, functional enrichment demonstrated significant upregulation of carbohydrate metabolism, including glycolysis and gluconeogenesis, hypoxia-inducible factor 1 signaling, protein processing in the endoplasmic reticulum, and bacterial infection defense pathways, while lysine degradation was uniquely downregulated. In the alcohol use disorder cohort, 19 pathways were significantly upregulated and nine were downregulated. The upregulated pathways in alcohol dependence prominently featured neurodegenerative disorder networks, including pathways for Alzheimer’s disease, Parkinson’s disease, and prion diseases, as well as oxidative phosphorylation, reactive oxygen species generation, and cellular necroptosis, driven by elevated expression of mitochondrial respiratory genes such as NDUFA13, SLC25A5, UQCRC1, COX4I1, and ATP5F1B.

Despite the depth of the transcriptomic datasets, the investigators emphasized several critical methodological limitations inherent to observational blood profiling. Because the study utilized circulating peripheral blood rather than central nervous tissue, the observed changes represent associative candidate molecular markers rather than confirmed causal mechanisms of addiction or neuroinflammation. Furthermore, despite excluding individuals with diagnosed viral hepatitis or human immunodeficiency virus, somatic medical conditions were prevalent among 50 percent of the alcohol cohort and substantial proportions of the psychoactive substance groups. The research team noted that unmeasured physiological stresses and polysubstance overlap could contribute to peripheral immune activation. Consequently, while these peripheral RNA alterations illuminate systemic immune-inflammatory cascades and mitochondrial metabolic strain associated with chronic substance use, direct functional and clinical validation will be required before these transcriptomic signatures can be applied in clinical diagnostics or targeted therapeutic interventions.

Subject of Research: Peripheral blood transcriptomic profiling of substance dependence and neuroimmune dysregulation

Article Title: Substance dependence: distinct transcriptomic patterns and neuroimmune system involvement in addiction pathogenesis and progression

Article References: Yakovchik, A., Spektor, E., Mamchur, A., Zelenova, Е., Ivanov, M., Kashtanova, D., Matkava, L., Terekhov, M., Tarasova, D., Petrova, V., Pavlov, K., Pavlova, O., Nebogina, K., Vyshinsky, K., Kozlov, A., Shport, S., Yudin, V., Keskinov, А., Yudin, S., & Skvortsova, V. (2026). Substance dependence: distinct transcriptomic patterns and neuroimmune system involvement in addiction pathogenesis and progression. Frontiers in Psychiatry, 17, Article 1904587. https://doi.org/10.3389/fpsyt.2026.1904587

Image Credits: AI Generated

DOI: 10.3389/fpsyt.2026.1904587

Keywords: transcriptomics, addiction, substance dependence, alcohol use disorder, peripheral blood, neuroinflammation, gene expression, CD177, GPR15, ELANE, RNA-seq, DESeq2, innate immunity, psychiatric genetics, KEGG pathway analysis, mitochondrial dysfunction

News Source: Juliet Wilcox. (November 14, 2026). Blood Transcriptome Analysis Links Substance Dependence to Persistent Neuroimmune Gene Alterations. Scienmag.

Tags: Addictionalcohol use disorderCD177DESeq2ELANEgene expressionGPR15Innate immunityKEGG pathway analysisMitochondrial dysfunctionNeuroinflammationperipheral bloodPsychiatric GeneticsRNA-Seqsubstance dependenceTranscriptomics
Share12Tweet7Share2ShareShareShare1

Related Posts

Staged Surgical Protocol Reconstructs Adolescent Mandible Following Ossifying Fibroma Resection

Staged Surgical Protocol Reconstructs Adolescent Mandible Following Ossifying Fibroma Resection

November 17, 2026
Comorbidities Associated With Lower RSV Humoral and Cellular Immunity in Older Adults

Comorbidities Associated With Lower RSV Humoral and Cellular Immunity in Older Adults

November 17, 2026

Visual Distraction Reduces Quantitative Light Touch Sensitivity in Healthy Adult Hand Testing

November 17, 2026

Herbal Iridoid Extract Relieves Fatty Liver Hemorrhagic Syndrome in Laying Hens

November 17, 2026

POPULAR NEWS

  • Staged Surgical Protocol Reconstructs Adolescent Mandible Following Ossifying Fibroma Resection

    Staged Surgical Protocol Reconstructs Adolescent Mandible Following Ossifying Fibroma Resection

    29 shares
    Share 12 Tweet 7
  • Microglia Study Identifies FKBP5 as a Regulator of Alzheimer’s Inflammation

    29 shares
    Share 12 Tweet 7
  • Holmium Substitution Improves SmFeO3 Supercapacitor Electrochemical Performance in KI/KOH Electrolyte

    29 shares
    Share 12 Tweet 7
  • Comorbidities Associated With Lower RSV Humoral and Cellular Immunity in Older Adults

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Staged Surgical Protocol Reconstructs Adolescent Mandible Following Ossifying Fibroma Resection

Microglia Study Identifies FKBP5 as a Regulator of Alzheimer’s Inflammation

Holmium Substitution Improves SmFeO3 Supercapacitor Electrochemical Performance in KI/KOH Electrolyte

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.